International Prescription Drug Parity Act
Bill journey · stage 1 of 5
Just introduced
What it doesSummary introduced in house (May 20, 1999)
International Prescription Drug Parity Act - Amends the Federal Food, Drug, and Cosmetic Act to require manufacturers of certain drugs manufactured and domestically approved and then exported, or domestically approved and manufactured in a registered foreign establishment, to: (1) maintain specified shipment compliance and labeling records; and (2) make such records available to U.S. importers.
Directs the Secretary of Health and Human Services to establish related criteria to facilitate the U.S. importation of such drugs.
What just happenedApr 12, 2000
Sponsor introductory remarks on measure. (CR H2186-2187)
Who’s behind it
- Introduced in HouseMay 20, 1999
- Apr 12, 2000IntroReferralB00100
Sponsor introductory remarks on measure. (CR H2186-2187)
- Jun 15, 1999CommitteeH11000
Referred to the Subcommittee on Health and Environment.
Health and Environment Subcommittee - May 20, 1999IntroReferralH11100
Referred to the House Committee on Commerce.
Energy and Commerce Committee - May 20, 1999IntroReferralIntro-H
Introduced in House
- May 20, 1999IntroReferral1000
Introduced in House